In the results announced on Monday, the company said the vaccine was found to be 79% effective. But the next day, the National Institute of Allergy and Infectious Diseases said it had been informed by data and safety officials monitoring the trial that information may have been used that provided an “incomplete view of the efficacy data”.
Click Here to Visit Orignal Source of Article https://www.bbc.co.uk/news/world-us-canada-56521166
